rituximab-chop-alemtuzumab
Showing 1 - 1 of 1
Chronic Lymphocytic Leukaemia, Patients Resistant to a Purine Analogous, Patients Relapsed With Purines Therapy Trial in Spain
Withdrawn
- Chronic Lymphocytic Leukaemia
- +2 more
- Rituximab-CHOP-Alemtuzumab
-
Badalona, Barcelona, Spain
- +31 more
Dec 28, 2011